ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| 1 |
Editas Medicine
EDIT
|
$5.13M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$4.86M |
| 3 |
Qualcomm
QCOM
|
$4.72M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
$4.26M |
| 5 |
Stratasys
SSYS
|
$4.24M |
Top Sells
| 1 |
Illumina
ILMN
|
$6.18M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$6.02M |
| 3 |
Netflix
NFLX
|
$4.72M |
| 4 |
NVIDIA
NVDA
|
$3.6M |
| 5 |
3D Systems Corporation
DDD
|
$3.41M |
Sector Composition
| 1 | Technology | 27.09% |
| 2 | Healthcare | 20.07% |
| 3 | Communication Services | 14.97% |
| 4 | Industrials | 13.28% |
| 5 | Consumer Discretionary | 11.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ultra Clean Holdings
UCTT
$1.05B
| $312K | 0.09% |
18,514
-15,223
| -45% | -$257K |
|
|
MZOR
77
DELISTED
Mazor Robotics Ltd.
MZOR
| $311K | 0.09% |
10,448
+2,088
| +25% | +$62.2K |
|
78
Howmet Aerospace
HWM
$70B
| $282K | 0.08% |
10,705
+9,429
| +739% | +$248K |
|
79
Regeneron Pharmaceuticals
REGN
$60B
| $267K | 0.08% |
690
+68
| +11% | +$26.3K |
|
80
Aptiv
APTV
$17.3B
| $258K | 0.07% |
3,202
-1,333
| -29% | -$107K |
|
81
Flex
FLEX
$20B
| $258K | 0.07% |
15,363
+3,072
| +25% | +$51.6K |
|
82
Inovio Pharmaceuticals
INO
$143M
| $243K | 0.07% |
36,773
+5,547
| +18% | +$36.7K |
|
83
Allient
ALNT
$759M
| $236K | 0.07% |
11,721
+5,421
| +86% | +$109K |
|
84
United Parcel Service
UPS
$72B
| $214K | 0.06% |
1,996
-349
| -15% | -$37.4K |
|
85
Ametek
AME
$42.3B
| $210K | 0.06% |
3,891
+619
| +19% | +$33.4K |
|
86
Box
BOX
$4.67B
| $197K | 0.06% |
12,080
+245
| +2% | +$4K |
|
87
Incyte
INCY
$16.9B
| $193K | 0.06% |
1,442
-830
| -37% | -$111K |
|
|
FARO
88
DELISTED
Faro Technologies
FARO
| $190K | 0.05% |
5,301
+911
| +21% | +$32.7K |
|
|
SYRS
89
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $131K | 0.04% |
8,245
+4,774
| +138% | +$75.9K |
|
|
FPRX
90
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $128K | 0.04% |
3,551
+351
| +11% | +$12.7K |
|
91
Adobe
ADBE
$147B
| $115K | 0.03% |
887
+118
| +15% | +$15.3K |
|
|
CELG
92
DELISTED
Celgene Corp
CELG
| $111K | 0.03% |
895
+88
| +11% | +$10.9K |
|
|
NNDM
93
Nano Dimension
NNDM
$293M
| $89K | 0.03% |
13,330
+2,664
| +25% | +$17.8K |
|
94
NextTrip
NTRP
$34.4M
| $55K | 0.02% |
+17,793
| New | +$55K |
|
|
CLLS
95
Cellectis
CLLS
$259M
| $54K | 0.02% |
+2,254
| New | +$54K |
|
|
JNCE
96
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $40K | 0.01% |
+1,811
| New | +$40K |
|
97
Evogene
EVGN
$10.7M
| $39K | 0.01% |
7,384
+731
| +11% | +$3.86K |
|
98
Apple
AAPL
$3.53T
| $34K | 0.01% |
+239
| New | +$34K |
|
99
ATI
ATI
$10.5B
| $33K | 0.01% |
1,835
+619
| +51% | +$11.1K |
|
100
Eastman Chemical
EMN
$7.76B
| $33K | 0.01% |
413
+91
| +28% | +$7.27K |
|